Seminars in Oncology
Volume 35, Supplement 1 , Pages S1-S17, February 2008

Optimizing Outcomes for Patients With Advanced Disease in Chronic Myelogenous Leukemia

  • Francis J. Giles

      Affiliations

    • Professor of Medicine, and Chief, Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio; and Director of CTRC Institute for Drug Development, San Antonio, TX.
    • These authors contributed equally to the development of this manuscript.
    • Corresponding Author InformationAddress correspondence to Francis J. Giles, MB, MD, FRCPI, FRCPath, Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio, Director of CTRC Institute for Drug Development, 7979 Wurzbach Road, Suite 400, San Antonio, TX 78229.
  • ,
  • Daniel J. DeAngelo

      Affiliations

    • Dana-Farber Cancer Institute, Boston, MA.
    • These authors contributed equally to the development of this manuscript.
  • ,
  • Michele Baccarani

      Affiliations

    • University of Bologna, Bologna, Italy.
  • ,
  • Michael Deininger

      Affiliations

    • Oregon Health & Science University, Portland, OR.
  • ,
  • François Guilhot

      Affiliations

    • Clinical Investigational Center INSERM, CHU de Poitiers, Poitiers, France.
  • ,
  • Timothy Hughes

      Affiliations

    • Institute of Medical and Veterinary Science, Adelaide, Australia.
  • ,
  • Michael Mauro

      Affiliations

    • Oregon Health & Science University, Portland, OR.
  • ,
  • Jerald Radich

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, WA.
  • ,
  • Oliver Ottmann

      Affiliations

    • Johann Wolfgang Goethe Universität, Frankfurt, Germany.
  • ,
  • Jorge Cortes

      Affiliations

    • Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • These authors contributed equally to the development of this manuscript.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00271-0

doi:10.1053/j.seminoncol.2007.12.002

Seminars in Oncology
Volume 35, Supplement 1 , Pages S1-S17, February 2008